Unfortunately, we still do not have any human data describing the potential neurological benefits of such treatment.
There is a paucity of realistic data describing the potential for entry of PCDD/Fs into the food supply via sewage sludge.
We will also highlight recent data describing the potential impact of TP53 mutations and p53 expression on the short- and long-term outcomes of lenalidomide treatment.
However this review also highlights that well-documented data describing the potential for SAE following n-3 supplementation are limited nor adequately reported to draw definitive conclusions concerning the safety associated with n-3 supplementation.
The measurement of changes in transcript or protein level, for example, is of limited use if the meta-data describing the potential reasons for the observed changed are not also detailed and stored alongside.
We describe the potential for data linkage across multiple registries, which allows for access to medical histories with follow-up time spanning birth to death.
This section describe the potential benefits and highlight potential application to leverage the clinical big data for analytical advantages using the MapReduce programming framework and the Hadoop platform.
Data have emerged describing the potential negative impact that RBC transfusion may have on outcomes, including increased ICU length of stay [4], nosocomial infections [5], multiorgan failure [6], acute lung injury [7 11], and mortality [2, 12, 13].
Data have emerged describing the potential negative impact that RBC transfusion may have on outcomes, including increased ICU length of stay [ 4], nosocomial infections [ 5], multiorgan failure [ 6], acute lung injury [ 7- 11], and mortality [ 2, 12, 13].
These data describe a potential mechanism driving the classical outcrossing hypothesis, which explains the benefits of deceptive orchid pollination via increased outcrossing (Dafni and Ivri 1979; Nilsson 1983; Ackerman 1986; Johnson and Nilsson 1999; Jersáková et al. 2006).
